Table 4 Evaluation performance (%) of the proposed ReMLA at rf \(=7\).
Isoforms | Acc | AUC | AUC-PR | Sen | Spe | MCC | F1-score | Pre |
---|---|---|---|---|---|---|---|---|
CYP1A2 | 57 | 88 | 72 | 62 | 78 | 38 | 57 | 53 |
CYP2C9 | 60 | 91 | 76 | 65 | 81 | 40 | 62 | 55 |
CYP2C19 | 58 | 92 | 78 | 66 | 80 | 39 | 60 | 52 |
CYP2D6 | 62 | 89 | 74 | 63 | 79 | 37 | 59 | 56 |
CYP3A4 | 59 | 93 | 79 | 60.5 | 84 | 45 | 61 | 55 |
Average | 59.2 | 90.6 | 75.8 | 64.3 | 80.4 | 39.8 | 59.8 | 54.2 |